ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RICHARD WOODS MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 761

$554K Total Retail Price of All Prescriptions

Rank: 96 out of 761

618 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 618 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 618 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

0% of this provider’s 10,260 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 695 657 1 2
LISINOPRIL 612 597 2 1
OMEPRAZOLE 546 533 3 4
ATENOLOL 493 485 4 8
LOSARTAN POTASSIUM 420 382 5 13
AMLODIPINE BESYLATE 374 366 6 6
FUROSEMIDE 289 287 7 7
K-TAB 278 272 8 46
LEVOTHROID 272 259 9 44
HYDROCHLOROTHIAZIDE 263 252 10 11
METOPROLOL TARTRATE 216 192 11 14
WARFARIN SODIUM 210 207 12 9
METFORMIN HCL 189 170 13 10
ATORVASTATIN CALCIUM 176 160 14 12
PRAVASTATIN SODIUM 172 172 15 20
GLIPIZIDE 168 153 16 39
HYDROCODONE-ACETAMINOPHEN 154 134 S3 17 5
GABAPENTIN 150 111 18 15
FLUTICASONE PROPIONATE 145 140 19 29
INSULIN SYRINGE 143 124 20 78
LEVOTHYROXINE SODIUM 142 131 21 3
TAMSULOSIN HCL 140 137 22 27
ALENDRONATE SODIUM 133 128 23 21
SERTRALINE HCL 132 132 24 25
TRAZODONE HCL 132 124 24 23
PROAIR HFA 121 116 26 32
ALLOPURINOL 114 104 27 28
TRIAMTERENE-HYDROCHLOROTHIAZID 96 96 28 68
CLONIDINE HCL 91 91 29 69
ADACEL 90 87 30 79
FINASTERIDE 88 88 31 73
NOVOLIN N 87 75 32 92
QVAR 87 85 32 107
FAMOTIDINE 83 72 34 60
NORTRIPTYLINE HCL 77 70 35 101
NOVOLIN R 76 65 36 152
PREDNISONE 72 69 37 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 61 38 35
NOVOLIN 70-30 68 59 39 175
AGGRENOX 68 68 39 121
NIFEDIPINE ER 64 57 41 128
CITALOPRAM HBR 64 54 41 19
MORPHINE SULFATE ER 62 37 S2 43 38
TERAZOSIN HCL 60 58 44 86
ISOSORBIDE MONONITRATE ER 60 60 44 72
FLUOXETINE HCL 58 55 46 31
DONEPEZIL HCL 58 58 46 33
BUPROPION HCL SR 58 58 46 93
SPIRONOLACTONE 58 51 46 45
OXYBUTYNIN CHLORIDE 57 45 50 85
NITROSTAT 55 55 51 176
DILT-XR 55 55 51 158
ATROVENT HFA 55 55 51 179
SPIRIVA 52 51 54 56
MELOXICAM 51 49 55 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.